• Cisapride (R 51619): Advancing Cardiac Safety and Translatio

  2026-07-20

  This thought-leadership article explores how Cisapride (R 51619) is reshaping translational research in cardiac electrophysiology and predictive safety. We synthesize mechanistic insights into 5-HT4 receptor signaling and hERG channel inhibition with strategic guidance for implementing modern phenotypic screening—especially in the context of iPSC-derived cardiomyocyte platforms and deep learning tools. Drawing on recent breakthroughs and positioning APExBIO's Cisapride as a benchmark reagent, we highlight best practices, cross-reference domain-leading content, and set a forward-looking agenda for translational investigators.

• Syringin Enhances Sunitinib Efficacy in Renal Cell Carcinoma

  2026-07-19

  This study demonstrates that Syringin, a natural compound from Acanthopanax senticosus, inhibits renal cell carcinoma (RCC) cell viability and proliferation by targeting the EGFR/PI3K/Akt signaling pathway. Notably, Syringin enhances the sensitivity of RCC cells to Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, suggesting a promising strategy to overcome drug resistance in RCC therapy.

• Refining In Vitro Drug Assessment: Insights from Schwartz 20

  2026-07-18

  Schwartz (2022) introduces a refined framework for distinguishing proliferation arrest from cell death in in vitro anti-cancer drug assessment, revealing that these effects are often conflated in traditional assays. This distinction improves experimental rigor and holds practical significance for evaluating kinase inhibitors and other targeted agents.

• Cefodizime: Advanced Applications for Infectious Disease Mod

  2026-07-17

  Cefodizime, a third-generation cephalosporin antibiotic, stands out for its robust spectrum, kidney-safe profile, and unique immunomodulatory effects. This article details experimental workflows, troubleshooting strategies, and innovative use-cases to maximize reproducibility and translational impact in infectious disease research.

• NS1-Driven DNMT1 Degradation Controls Bocavirus Replication

  2026-07-17

  Qin et al. reveal that the NS1 protein of human bocavirus 1 (HBoV1) drives proteasomal degradation of host DNMT1, directly regulating viral DNA methylation and post-transcriptional RNA processing. This work establishes DNMT1 as a pivotal epigenetic factor in HBoV1 replication and highlights new directions for antiviral research targeting host-virus epigenetic interactions.

• Capsaicin: Applied Workflows for Pain and Cancer Research

  2026-07-16

  Capsaicin ((E)-Capsaicin) stands out as both a TRPV1 ion channel activator and a KDM1A/LSD1 inhibitor, enabling dual-mechanism research in pain, inflammation, and oncology. Discover precise workflows, troubleshooting tips, and innovative use-cases powered by APExBIO’s validated compound.

• Biotin (Vitamin B7): Mechanisms and Protocols for Research

  2026-07-16

  Biotin (Vitamin B7) is a water-soluble B-vitamin serving as a coenzyme for five critical carboxylases in human metabolism. It is an indispensable reagent for protein biotinylation and molecular biology. APExBIO’s A8010 Biotin provides high-purity, robust solutions for protein labeling and advanced metabolic studies.

• Calpain Inhibitor I, ALLN: Technical Parameters & Lab Setup

  2026-07-15

  Calpain Inhibitor I, ALLN provides a selective and potent tool for researchers investigating calpain- and cathepsin-mediated pathways in apoptosis assays and ischemia-reperfusion injury models. It is recommended for mechanistic studies in preclinical and inflammation research, but is not intended for diagnostic or medical applications.

• AAL-993 (SKU C3730): Reliable VEGF Inhibition in Tumor Resea

  2026-07-15

  This article details how AAL-993 (SKU C3730) addresses common reproducibility and sensitivity challenges in cell-based angiogenesis assays. By integrating data-driven guidance and practical Q&A, researchers can optimize experimental reliability and workflow with this potent VEGF receptor inhibitor.

• Rapid Purification of Recombinant Annexin V for Biophysical

  2026-07-14

  This study presents a streamlined and highly effective method for purifying recombinant annexin V, yielding protein suitable for detailed biophysical analysis. The protocol leverages calcium-dependent liposome binding and minimizes contaminants, supporting advances in ion channel research and recombinant protein workflows.

• EZ Cap EGFP mRNA 5-moUTP: Optimizing Reporter Assays & Imagi

  2026-07-14

  EZ Cap™ EGFP mRNA (5-moUTP) empowers researchers with ultra-stable, immune-evasive enhanced green fluorescent protein mRNA for reliable gene expression, translation efficiency assays, and in vivo imaging. Discover workflow optimizations, troubleshooting, and data-driven protocol enhancements to unlock its full potential in next-generation research.

• Cabazitaxel (XRP6258): Technical Parameters for Resistant Mo

  2026-07-13

  Cabazitaxel (XRP6258) addresses the challenge of taxane resistance in cancer research, particularly in P-glycoprotein-expressing cell lines and taxane-resistant tumor models. It is optimal for use in DMSO- or ethanol-based workflows but should not be used in aqueous systems or for protocols requiring long-term solution storage.

• Sunitinib (SKU B1045): Reliable RTK Inhibitor for Cancer Res

  2026-07-13

  This article provides practical, scenario-driven guidance for optimizing cancer cell viability, proliferation, and cytotoxicity assays using Sunitinib (SKU B1045). Drawing on peer-reviewed evidence and real laboratory challenges, it highlights how APExBIO’s Sunitinib ensures reproducibility, workflow compatibility, and robust data for renal cell carcinoma and other advanced cancer models.

• Cytarabine (AraC): Precision Apoptosis Induction in Leukemia

  2026-07-12

  Cytarabine (AraC) offers unmatched control in dissecting apoptosis and DNA damage responses in leukemia research, with built-in resistance modeling and p53 pathway interrogation. This guide delivers protocol enhancements, troubleshooting insights, and actionable takeaways rooted in current cross-domain findings.

• Ceramide-Driven Autophagy Fuels Nodavirus Replication in Fis

  2026-07-10

  This study reveals that red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism in host cells to enhance replication through autophagy. The lipidomics-driven findings provide molecular insight into viral pathogenesis, highlighting ceramide flux as a promising target for antiviral research and aquaculture disease management.

15605 records 1/1041 page Next 12345 下5页 Last page